Phase II Clinical Trial of CD34+ Cell Therapy to Explore Endpoint Selection and Timing in Patients With Critical Limb IschemiaYasuyuki Fujita, Atsuhiko Kawamoto, Yutaka Furukawa et al.|Circulation Journal|2013Cited by 70